3D models of Alzheimer's disease patient microglia recapitulate disease phenotype and show differential drug responses compared to 2D
Cuni-Lopez, C.; Quek, H.; Oikari, L. E.; Stewart, R.; Nguyen, T. H.; Sun, Y.; Guo, C. C.; Lupton, M. K.; White, A. R.
Show abstract
Alzheimers disease (AD) is an incurable neurodegenerative disorder with a rapidly increasing prevalence worldwide. Current approaches targeting hallmark pathological features of AD have had no consistent clinical benefit. Neuroinflammation is a major contributor to neurodegeneration and hence, microglia, the brains resident immune cells, are an attractive target for potentially more effective therapeutic strategies. However, there is no current in vitro model system that faithfully recapitulates patient-specific microglial characteristics. To address this shortcoming, we developed novel 3D models of monocyte-derived microglia-like cells (MDMi) from AD patients. MDMi in 3D exhibited mature microglial features, including a highly branched morphology and enhanced bonafide microglial marker expression compared to 2D. Moreover, AD MDMi in 3D co-cultures with neuro-glial cells showed altered cell-to-cell interactions, growth factor and cytokine secretion profiles and responses to amyloid-{beta}. Drug screening assays in 3D AD MDMi revealed different cytokine responses compared to 2D. Our study demonstrates disease- and drug-specific responses in 3D MDMi models that are not apparent in 2D and presents a new 3D platform for more effective and personalised drug testing.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- iPSC-Derived PSEN2 (N141I) Astrocytes and Microglia Exhibit a Primed Inflammatory Phenotype 97%
- Astrocytic C-X-C motif chemokine ligand-1 mediates β-amyloid-induced tau mislocalization and synaptotoxicity 95%
- 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner 94%
Similar papers in this journal
- Alzheimer's Disease Patient Brain Extracts Induce Multiple Pathologies in Vascularized Neuroimmune Organoids for Disease Modeling and Drug Discovery 97%
- SARS-CoV-2 promotes microglial synapse elimination in human brain organoids 95%
- Tau depletion in human neurons mitigates A beta-driven toxicity 95%
Similar papers in this journal
- Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction, progression, and prion-like spread of Alzheimer s disease pathogenesis 95%
- Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer's disease. 95%
- C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimers disease 95%
Similar papers in this journal
- Selective agonism of GPR34 stimulates microglial uptake and clearance of amyloid β fibrils 94%
- A Human Neuron Alzheimer's Disease Model Reveals Barriers to Senolytic Translatability 93%
- Age, Sex and Alzheimer's disease: A longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.